Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus
Crossref DOI link: https://doi.org/10.1007/s13300-016-0170-2
Published Online: 2016-04-25
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Katsuno, Tomoyuki
Ikeda, Hiroki
Namba, Mitsuyoshi
Text and Data Mining valid from 2016-04-25
Article History
Received: 23 February 2016
First Online: 25 April 2016